Nplate 500 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHNS6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,670
Award facts
- Contract value 100% obligated
- $13,669.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,669.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 500 microgram vials of Nplate. The award, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036.
The PPV-G GEN V contract represents a critical component of the Defense Logistics Agency's $30.3 billion pharmaceutical supply strategy, authorizing DMS Pharmaceutical Group to serve as a regional prime vendor contractor supplying branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. Nplate is a thrombopoietin receptor agonist used to treat thrombocytopenia, reflecting the breadth of specialty pharmaceutical products DMS Pharmaceutical Group supplies across the federal military medical system. The vendor's established performance on numerous delivery orders demonstrates its capacity to fulfill the diverse and specialized pharmaceutical requirements of DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FHNS6?
SPE2DR26FHNS6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FHNS6 worth?
The government has obligated $13,670 on SPE2DR26FHNS6.
Is contract SPE2DR26FHNS6 an order under another contract?
Yes. SPE2DR26FHNS6 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNS6 competed?
The extent of competition for SPE2DR26FHNS6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award